Suppr超能文献

单核细胞增生李斯特菌的体外药敏性,特别参考新型β-内酰胺类抗生素(作者译)

[In vitro susceptibility of Listeria monocytogenes with special reference to newer beta lactam antibiotics (author's transl)].

作者信息

Marklein G, Häfelein J

出版信息

Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol. 1981 Dec;251(1):40-53.

PMID:6277101
Abstract

Minimal inhibitory (MIC) and minimal lethal concentrations (MLC) of ampicillin, mezlocillin, piperacillin, cephalothin, cefamandole cefoxitin, cefuroxime, cefotaxime, gentamicin, and doxycycline against 44 strain of Listeria monocytogenes from clinical specimens were determined by broth dilution tests. With regard to the MIC90 and MLC90 values (concentrations which inhibited or killed 90 percent of the strains) ampicillin showed the greatest anti-listeric activity with 0,48 and 20,8 microgram/ml. The corresponding results for mezlocillin were 8,0 and 54,4 microgram/ml, for piperacillin 5,2 and 128 microgram/ml, resp. Among the cephalosporins, cephalothin showed the best activity (MIC90, 5,8 microgram/ml, MLC90, 76,8 microgram/ml). The MIC90 values of cefamandole and cefoxitin were 7,8 and 89,6 microgram/ml, resp. and the MLC90 was more than 128 microgram/ml while there was no clinically relevant activity of cefuroxime and cefotaxime (MIC90 more than 128 microgram/ml). The MIC90 and MLC90 results of gentamicin were 12 and 15,2 microgram/ml, resp, and those of doxycycline 8 and 25,6 microgram/ml, resp. There were only slight differences between gentamicin MIC and MLC values. Henceforward the drug of choice for the treatment of generalized listeric infections should be ampicillin eventually in combination with gentamicin.

摘要

采用肉汤稀释试验测定了氨苄西林、美洛西林、哌拉西林、头孢噻吩、头孢孟多、头孢西丁、头孢呋辛、头孢噻肟、庆大霉素和多西环素对44株临床分离的单核细胞增生李斯特菌的最低抑菌浓度(MIC)和最低致死浓度(MLC)。就MIC90和MLC90值(抑制或杀死90%菌株的浓度)而言,氨苄西林的抗李斯特菌活性最强,MIC90和MLC90分别为0.48微克/毫升和20.8微克/毫升。美洛西林的相应结果分别为8.0微克/毫升和54.4微克/毫升,哌拉西林分别为5.2微克/毫升和128微克/毫升。在头孢菌素类中,头孢噻吩活性最佳(MIC90为5.8微克/毫升,MLC90为76.8微克/毫升)。头孢孟多和头孢西丁的MIC90值分别为7.8微克/毫升和89.6微克/毫升,MLC90大于128微克/毫升,而头孢呋辛和头孢噻肟无临床相关活性(MIC90大于128微克/毫升)。庆大霉素的MIC90和MLC90结果分别为12微克/毫升和15.2微克/毫升,多西环素分别为8微克/毫升和25.6微克/毫升。庆大霉素的MIC和MLC值仅有细微差异。今后,治疗全身性李斯特菌感染的首选药物应为氨苄西林,最终可联合庆大霉素使用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验